Inozyme Pharma (NASDAQ:INZY) Earns “Equal Weight” Rating from Wells Fargo & Company
Wells Fargo & Company reiterated their equal weight rating on shares of Inozyme Pharma (NASDAQ:INZY – Free Report) in a research report sent to investors on Friday morning,Benzinga reports. The brokerage currently has a $4.00 target price on the stock. Other analysts have also issued research reports about the company. Jefferies Financial Group reiterated a […]
Wells Fargo & Company reiterated their equal weight rating on shares of Inozyme Pharma (NASDAQ:INZY – Free Report) in a research report sent to investors on Friday morning,Benzinga reports. The brokerage currently has a $4.00 target price on the stock. Other analysts have also issued research reports about the company. Jefferies Financial Group reiterated a […]
